Handbook of phase I/II clinical drug trials

Designing a drug development program or key study can be a daunting task due to growing limitations on time and resources in industry and in academia. Scientific advances and increasing competition in the drug development arena demand a quick, easy-to-use source of data. The Handbook of Phase I/II C...

Full description

Saved in:
Bibliographic Details
Other Authors: O'Grady, John (Editor), Joubert, Pieter H. (Editor)
Format: Book
Language:English
Published: Boca Raton CRC Press 1997
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000 i 4501
001 wils-265565
005 2020922122025
008 t1997 XXU a #0 eng
020 # # |a 9780849392306  |q hardback 
020 # # |a 0849392306  |q hardback 
040 # # |a DNLM  |c DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QV 771 
090 0 0 |a QV771  |b H2367 1997 
245 1 1 |a Handbook of phase I/II clinical drug trials  |c edited by John O'Grady and Pieter H. Joubert 
264 # 1 |a Boca Raton  |b CRC Press  |c 1997 
264 # 2 |c ©1997 
300 # # |a 562 pages  |b illustrations  |c 25 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a Designing a drug development program or key study can be a daunting task due to growing limitations on time and resources in industry and in academia. Scientific advances and increasing competition in the drug development arena demand a quick, easy-to-use source of data. The Handbook of Phase I/II Clinical Drug Trials is that source. It is an indispensable guide, readily providing the information needed to make crucial decisions regarding drug therapies. This book makes it easy to plan cost-effective, early drug development programs. The first four sections of the text deal with the preliminaries to studying drugs in humans, as well as considerations common to early drug trials in human subjects. Part II considers organization and decision making factors. Ethical and legal considerations are discussed in the next section. Subsequent chapters deal with specific therapeutic areas and indications. Areas of growing importance, such as studying in vitro metabolism in human hepatocytes and genetic engineering are highlighted as well. The Handbook of Phase I/II Clinical Drug Trials is your complete guide to successful early drug development 
650 1 2 |a Drug Evaluation 
650 2 2 |a Clinical Trials, Phase I as Topic 
650 2 2 |a Clinical Trials, Phase II as Topic 
700 1 # |a O'Grady, John  |e editor 
700 1 # |a Joubert, Pieter H.  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=265565 
964 # # |c BOK  |d MD